Get started
Award

82272819)

Funded outputs count: 24
Funder award ID: 82272819)
OpenAlex ID: G3441248127
A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer
2026 · Yan Liu, Beibei Ran, et al. · Journal of Gastroenterology
PDF
Modulation of gut microbiota and intestinal barrier by lotus seed, jujube, and longan aril in senna leaf-induced diarrhea in mice
2026 · Fangkun Zhao, Rongrong Xiao, et al. · Frontiers in Microbiology
PDF
An ICOSL-armed oncolytic adenovirus activates CD4+ T cell to potentiate antitumor immunity and synergizes with anti-PD-1 or CAR-T cell therapy in colorectal cancer
2026 · Wencui Liu, Xuanqi Ren, et al. · BMC Medicine
A CDK4/6 inhibitor-armed oncolytic adenovirus reverses T cell exhaustion through the Rb-p65-CCL5 pathway and potentiates the antitumor activity of anti-PD-1 or CAR-T therapy in colorectal cancer
2026 · Dan Zhou, Beibei Ran, et al. · Frontiers in Immunology · 1
PDF
Re-balancing immunity with CRISPR-Cas9: Novel strategies for cancer and autoimmune disorders
2026 · Xuanqi Ren, Ziyang Zhou, et al. · Biotechnology Advances · 3
The commensal microbiome in respiratory tract tumors: From oncogenic mechanisms to clinical translation
2026 · Jiale Yu, Ciliang Guo, et al. · Journal of Advanced Research
Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8+ T cells
2026 · Lingkai Kong, Kua Liu, et al. · Communications Medicine · 1
PDF
In situ extended immune activation instantly after tumor resection by oncolytic virus controls postoperative tumor recurrence
2025 · Ciliang Guo, Tian Gao, et al. · Cell Reports Medicine · 29
Dynamic remodeling of amino acid metabolism in tumor-associated macrophages: Fueling immunosuppression, reshaping tumor niches, and unlocking metabolic checkpoints
2025 · Beibei Ran, Lingjun Xiao, et al. · Journal of Advanced Research · 8
Serotonin (5‐Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities
2025 · Yuxin Zhang, Nan Wang, et al. · MedComm · 38
SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy
2025 · Peng Wang, Jiannan Qiu, et al. · Cell Death and Differentiation · 22
PDF
EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma
2024 · Lili Hu, Weiwei Shi, et al. · Frontiers in Medicine · 10
Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy
2024 · Kua Liu, Lingkai Kong, et al. · Cell Reports Medicine · 66
“Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity
2024 · Lingjun Xiao, Louqian Zhang, et al. · 癌症：英文版 · 85
Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGF β2 and EMT
2024 · Lingkai Kong, Qinyu He, et al. · FEBS Open Bio · 2
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway
2024 · Ding Ma, Shuwen Liu, et al. · Cancer Biology & Therapy · 13
Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway
2023 · Qinyu He, Lingkai Kong, et al. · Heliyon · 11
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
2023 · Ciliang Guo, Lingkai Kong, et al. · Cell & Bioscience · 44
PDF
UBE2S promotes malignant properties via VHL / HIF ‐1α and VHL / JAK2 / STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
2023 · Junyi Wu, Junyi Wu, et al. · Cancer Medicine · 15
PDF
Ezetimibe suppresses the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT
2023 · Qinyu He, Ding Ma, et al. · Research Square
PDF
A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinoma
2023 · Ding Ma, Shuwen Liu, et al. · Scientific Reports · 1
PDF
Identification of a Interferon-Stimulated gene Signature for Predicting Prognosis, Tumor Microenvironment, and Drug Candidates in Hepatocellular Carcinoma
2023 · Shuo Wang, Zhonghan Zhou, et al. · Research Square
PDF
Hypoxia signaling in cancer: Implications for therapeutic interventions
2023 · Yan Zhuang, Kua Liu, et al. · MedComm · 117
PDF
Effect of Radiation on Some Mechanical Properties of an Epoxy System.
1971 · A. Tilmans, Edward M. Krokosky · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 2
Year
Topic